Engineers Gate Manager LP - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 115 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q2 2020. The put-call ratio across all filers is 1.42 and the average weighting 0.1%.

Quarter-by-quarter ownership
Engineers Gate Manager LP ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q2 2023$505,112
+102.8%
17,612
+69.5%
0.02%
+90.0%
Q1 2023$249,048
-75.3%
10,390
-65.1%
0.01%
-84.6%
Q2 2021$1,007,000
+45.7%
29,749
+77.9%
0.06%
+91.2%
Q1 2021$691,000
+51.5%
16,725
+59.0%
0.03%
+70.0%
Q4 2020$456,000
-39.7%
10,517
-34.9%
0.02%
-47.4%
Q2 2020$756,000
+147.9%
16,164
-27.9%
0.04%
+72.7%
Q1 2020$305,000
+127.6%
22,416
+71.9%
0.02%
+214.3%
Q3 2019$134,00013,0430.01%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q2 2020
NameSharesValueWeighting ↓
Tri Locum Partners LP 208,886$5,337,0371.71%
Portolan Capital Management 276,505$7,064,7030.66%
Green Alpha Advisors, LLC 21,538$550,2960.42%
Nikko Asset Management Americas, Inc. 1,388,574$35,422,5230.42%
SummerHaven Investment Management, LLC 22,326$570,4290.42%
ARK Investment Management 1,901,546$48,584,5080.37%
Granahan Investment Management 398,862$10,190,9240.36%
FEDERATED HERMES, INC. 4,711,512$120,379,1320.32%
Woodline Partners LP 1,069,814$27,333,7480.32%
Diametric Capital, LP 26,130$667,6210.28%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders